DrugPatentWatch Database Preview
LYMPHOSEEK KIT Drug Profile
Which patents cover Lymphoseek Kit, and when can generic versions of Lymphoseek Kit launch?
Lymphoseek Kit is a drug marketed by Cardinal Health 414 and is included in one NDA. There are two patents protecting this drug.
This drug has twenty-four patent family members in eleven countries.
The generic ingredient in LYMPHOSEEK KIT is technetium tc-99m tilmanocept. There are four drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the technetium tc-99m tilmanocept profile page.
Summary for LYMPHOSEEK KIT
International Patents: | 24 |
US Patents: | 2 |
Applicants: | 1 |
NDAs: | 1 |
Suppliers / Packagers: | 2 |
Clinical Trials: | 16 |
DailyMed Link: | LYMPHOSEEK KIT at DailyMed |

Generic Entry Opportunity Date for LYMPHOSEEK KIT
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
US Patents and Regulatory Information for LYMPHOSEEK KIT
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cardinal Health 414 | LYMPHOSEEK KIT | technetium tc-99m tilmanocept | INJECTABLE;INJECTION | 202207-001 | Mar 13, 2013 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | |||
Cardinal Health 414 | LYMPHOSEEK KIT | technetium tc-99m tilmanocept | INJECTABLE;INJECTION | 202207-001 | Mar 13, 2013 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
Cardinal Health 414 | LYMPHOSEEK KIT | technetium tc-99m tilmanocept | INJECTABLE;INJECTION | 202207-001 | Mar 13, 2013 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | Y | ➤ Sign Up | ||
Cardinal Health 414 | LYMPHOSEEK KIT | technetium tc-99m tilmanocept | INJECTABLE;INJECTION | 202207-001 | Mar 13, 2013 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
International Patents for LYMPHOSEEK KIT
Country | Document Number | Estimated Expiration |
---|---|---|
China | 102301429 | ➤ Sign Up |
South Korea | 101765717 | ➤ Sign Up |
World Intellectual Property Organization (WIPO) | 2010087959 | ➤ Sign Up |
Germany | 60014359 | ➤ Sign Up |
Spain | 2228536 | ➤ Sign Up |
South Korea | 20170027874 | ➤ Sign Up |
Japan | 2017066148 | ➤ Sign Up |
Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for LYMPHOSEEK KIT
Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|
0736 | Netherlands | ➤ Sign Up | PRODUCT NAME: TILMANOCEPT, DESGEWENST GELABELD MET TECHNETIUM TC 99M; REGISTRATION NO/DATE: EU/1/14/955 20141119 |
C0033 | France | ➤ Sign Up | PRODUCT NAME: TILMANOCEPT; REGISTRATION NO/DATE: EU/1/14/955 20141121 |
90025-1 | Sweden | ➤ Sign Up | PRODUCT NAME: TILMANOCEPT; REG. NO/DATE: EU/1/14/955 20141120 |
Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |